Organ Biology
Online ISSN : 2188-0204
Print ISSN : 1340-5152
ISSN-L : 1340-5152
佐野 元昭
ジャーナル フリー

2016 年 23 巻 2 号 p. 117-120


Early application of therapeutic hypothermia, rapid achievement of target cooling temperature were key factors for improving survival and neurological outcomes. In the present situation, targeted Temperature Management (TTM) is applied to only a minority of post-cardiac arrest patients. We have been looking forward to seeing widely applicable therapeutic approaches. We previously demonstrated that both inhalation of 2% hydrogen gas and TTM (33°C), starting at the beginning of cardiopulmonary resuscitation and given for 2 hours after return of spontaneous circulation (ROSC), yielded comparable improvement in survival and neurological deficit after ROSC in a rat model of cardiac arrest. However, in a clinical setting, hypothermia is applied after ROSC. We have confirmed that the benefit of hydrogen inhalation is similar when begun after ROSC.
We would like to emphases a salutary effect of hydrogen gas inhalation on the neurological outcome after cardiopulmonary resuscitation independently of TTM in rats. Inhalation hydrogen gas therapy, either alone or in the combined with TTM, could represent a promising strategy to improve brain resuscitation for post cardiac arrest patients in the near future.

© 2016 日本臓器保存生物医学会
前の記事 次の記事